LONDON, May 8, 2017 /PRNewswire/ -- About Kaposi Sarcoma
Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, epidemic, and iatrogenic forms. Epidemic or acquired immune deficiency syndrome (AIDS)-associated form of treatment is one of the most prevalent types followed in the treatment of Kaposi sarcoma globally. The diagnosis is done by biopsy, and major treatment types include chemotherapy, HAART, and immunotherapy. HAART is the most common type of treatment due to a high prevalence rate of AIDS-associated Kaposi sarcoma. Download the full report: https://www.reportbuyer.com/product/4886912/Technavio's analysts forecast the global Kaposi sarcoma market to grow at a CAGR of 2.46% during the period 2017-2021. Covered in this report
The report covers the present scenario and the growth prospects of the global Kaposi sarcoma market for 2017-2021. To calculate the market size, the report considers the sales of both generic as well as branded drugs. The market is divided into the following segments based on geography:
Americas APAC EMEA Technavio's report, Global Kaposi Sarcoma Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors
Bristol-Myers Squibb GlaxoSmithKline Johnson & Johnson Merck Other prominent vendors
Eli Lilly Pfizer Market driver
Rising number of organ transplants For a full, detailed list, view our report Market challenge
High cost of treatment For a full, detailed list, view our report Market trend
Increasing consolidation in the cancer treatment market For a full, detailed list, view our report Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report. Methodology
Download the full report: https://www.reportbuyer.com/product/4886912/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected]
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-kaposi-sarcoma-market-2017-2021-300453692.html
SOURCE ReportBuyer
